Search research articles
Contact Us
Filters
Showing results (1-10 of 107) with videos related to
Page
of 11
Sort By:
Drugs in Context
|
July 3, 2025
Advancing endometrial cancer treatment: exploring immunotherapy and tyrosine kinase inhibitors through clinical cases
Vanda Salutari
Current Opinion in Obstetrics & Gynecology
|
January 3, 2024
Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives
Vanda Salutari, Elena Giudice, Domenica Lorusso
World Journal of Surgical Oncology
|
August 30, 2008
Conservatively treated glassy cell carcinoma of the cervix
Gabriella Ferrandina, Vanda Salutari, Marco Petrillo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 16, 2021
Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial)
Claudia Marchetti, Riccardo Tudisco, Vanda Salutari, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 12, 2006
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations
Gabriella Ferrandina, Francesco Legge, Vanda Salutari, et al.
BMC Cancer
|
June 28, 2006
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature
Gabriella Ferrandina, Vanda Salutari, Antonia Testa, et al.
Expert Review of Anticancer Therapy
|
November 1, 2017
Optimizing treatment in recurrent epithelial ovarian cancer
Giacomo Corrado, Vanda Salutari, Eleonora Palluzzi, et al.
Gynecologic Oncology
|
January 31, 2004
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients
Andrea Fattorossi, Alessandra Battaglia, Gabriella Ferrandina, et al.
Cancer
|
March 26, 2004
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma
Andrea Fattorossi, Alessandra Battaglia, Gabriella Ferrandina, et al.
Annals of Surgical Oncology
|
June 4, 2015
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study
Marco Petrillo, Ida Paris, Giuseppe Vizzielli, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 107) with videos related to
Sort By:
Page
of 11
Drugs in Context
|
July 3, 2025
Advancing endometrial cancer treatment: exploring immunotherapy and tyrosine kinase inhibitors through clinical cases
Vanda Salutari
Current Opinion in Obstetrics & Gynecology
|
January 3, 2024
Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives
Vanda Salutari, Elena Giudice, Domenica Lorusso
World Journal of Surgical Oncology
|
August 30, 2008
Conservatively treated glassy cell carcinoma of the cervix
Gabriella Ferrandina, Vanda Salutari, Marco Petrillo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 16, 2021
Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial)
Claudia Marchetti, Riccardo Tudisco, Vanda Salutari, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 12, 2006
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations
Gabriella Ferrandina, Francesco Legge, Vanda Salutari, et al.
BMC Cancer
|
June 28, 2006
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature
Gabriella Ferrandina, Vanda Salutari, Antonia Testa, et al.
Expert Review of Anticancer Therapy
|
November 1, 2017
Optimizing treatment in recurrent epithelial ovarian cancer
Giacomo Corrado, Vanda Salutari, Eleonora Palluzzi, et al.
Gynecologic Oncology
|
January 31, 2004
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients
Andrea Fattorossi, Alessandra Battaglia, Gabriella Ferrandina, et al.
Cancer
|
March 26, 2004
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma
Andrea Fattorossi, Alessandra Battaglia, Gabriella Ferrandina, et al.
Annals of Surgical Oncology
|
June 4, 2015
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study
Marco Petrillo, Ida Paris, Giuseppe Vizzielli, et al.
Page
of 11